Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/79363
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ngo, S. | - |
dc.contributor.author | Stupans, I. | - |
dc.contributor.author | McKinnon, R. | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Epilepsy and Behavior, 2013; 26(1):64-66 | - |
dc.identifier.issn | 1525-5050 | - |
dc.identifier.issn | 1525-5069 | - |
dc.identifier.uri | http://hdl.handle.net/2440/79363 | - |
dc.description.abstract | There have been considerable debates about bioequivalence and generic substitution of certain critical care drugs. We aimed to understand patient attitudes and perceptions about generic substitution in the treatment of epilepsy. In this pilot study, a self-administered anonymous survey was completed by 47 patients with epilepsy. The response rate by postal mail was 6.7%. More than 70% of the patients were concerned about the effectiveness of generic antiepileptic drugs, and 68% of the patients were not comfortable receiving generics to treat their epilepsy. About 87% of the patients thought that their antiepileptic drug should only be substituted with a generic with their consent, and 64% of the patients believed that substitution should only take place with the consent of their doctor. Considerable concern exists among patients about generic substitution in the treatment of epilepsy. More data regarding whether generic antiepileptic drugs are bioequivalent in clinical situations would help to address patient concerns. | - |
dc.description.statementofresponsibility | Suong N.T. Ngo, Ieva Stupans, Ross A. McKinnon | - |
dc.language.iso | en | - |
dc.publisher | Academic Press Inc Elsevier Science | - |
dc.rights | © 2012 Elsevier Inc. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.yebeh.2012.10.032 | - |
dc.subject | Humans | - |
dc.subject | Epilepsy | - |
dc.subject | Anticonvulsants | - |
dc.subject | Health Surveys | - |
dc.subject | Attitude to Health | - |
dc.subject | Perception | - |
dc.subject | Age Factors | - |
dc.subject | Therapeutic Equivalency | - |
dc.subject | Adult | - |
dc.subject | Aged | - |
dc.subject | Aged, 80 and over | - |
dc.subject | Middle Aged | - |
dc.subject | Australia | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.subject | Young Adult | - |
dc.subject | Drug Substitution | - |
dc.title | Generic substitution in the treatment of epilepsy: Patient attitudes and perceptions | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.yebeh.2012.10.032 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Ngo, S. [0000-0002-9050-6894] | - |
Appears in Collections: | Animal and Veterinary Sciences publications Aurora harvest 4 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.